VVOS
Vivos Therapeutics (VVOS)
$53
About Vivos Therapeutics (VVOS)
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.
Details
Daily high
$3.59
Daily low
$3.41
Price at open
$3.56
52 Week High
$6.28
52 Week Low
$1.91
Market cap
20.8M
Dividend yield
0.00%
Volume
32,222
Avg. volume
136,406
P/E ratio
-.71
Vivos Therapeutics News
Details
Daily high
$3.59
Daily low
$3.41
Price at open
$3.56
52 Week High
$6.28
52 Week Low
$1.91
Market cap
20.8M
Dividend yield
0.00%
Volume
32,222
Avg. volume
136,406
P/E ratio
-.71